Atmospheric Pressure and Epistaxis Relationship
Launched by SAGLIK BILIMLERI UNIVERSITESI · Jul 29, 2024
Trial Information
Current as of July 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how changes in atmospheric pressure, like what you might experience during weather changes, might affect blood pressure and potentially lead to nosebleeds (called epistaxis). The researchers want to understand if these pressure changes play a role in why some people have nosebleeds, whether they are currently bleeding or have had a nosebleed in the past.
To participate in this study, you need to be at least 18 years old and have visited the emergency department for a nosebleed. The trial is open to anyone living in central districts of Ankara, but unfortunately, it does not include people under 18, pregnant women, or those who have had certain surgeries or injuries related to their face. If you decide to join, you will be helping researchers gather important information that could improve our understanding of this common issue.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 18 and above Presenting to the emergency department with complaints of epistaxis, whether active or resolved.
- • Willing volunteers consenting to participate in the study. Residing in central districts of Ankara
- Exclusion Criteria:
- • Patients under the age of 18. Pregnant individuals. Those with a history of maxillofacial surgery. Patients reporting a history of trauma at the time of admission. Patients stating they are from a city other than Ankara.
About Saglik Bilimleri Universitesi
Saglik Bilimleri Universitesi, or the University of Health Sciences, is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university focuses on translating scientific discoveries into practical applications that enhance patient care and public health outcomes. Its commitment to rigorous ethical standards and comprehensive training equips researchers and healthcare professionals to contribute effectively to the global medical community. Through its clinical trial initiatives, Saglik Bilimleri Universitesi aims to address pressing health challenges and foster the development of new therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Yenimahalle, Turkey
Patients applied
Trial Officials
gulsen akcay, ass. prof.
Study Director
ass. prof. of organization
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported